Last Updated: November 9, 2026

List of Supplementary Protection Certificates

« Back to Dashboard

Biologic Drug Supplementary Protection Certificates

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	3482771	2390019-4	Sweden	PRODUCT NAME: PEANUT PROTEIN AS DEFATTED POWDER OF ARACHIS HYPOGAEA L. SEMEN (PEANUTS); REG. NO/DATE: EU/1/20/1495 20201221	⤷ Start Trial
European Patent Office	1824988	C20190023 00296	Estonia	PRODUCT NAME: ALFADAMOKTOKOGPEGOOL;REG NO/DATE: EU/1/18/1324 26.11.2018	⤷ Start Trial
European Patent Office	2567976	300915	Netherlands	PRODUCT NAME: DARATUMUMAB; REGISTRATION NO/DATE: EU/1/16/1101/001-002 20160524	⤷ Start Trial
European Patent Office	2100614	C 2017 013	Romania	PRODUCT NAME: OLARATUMAB; NATIONAL AUTHORISATION NUMBER: EU/1/16/1143; DATE OF NATIONAL AUTHORISATION: 20161109; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/16/1143; DATE OF FIRST AUTHORISATION IN EEA: 20161109	⤷ Start Trial
European Patent Office	2340033	300880	Netherlands	PRODUCT NAME: SNELWERKENDE INSULIN ASPART; REGISTRATION NO/DATE: EU/1/16/1160 20170109	⤷ Start Trial
European Patent Office	2487162	132017000002735	Italy	PRODUCT NAME: COBICISTAT O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE O UN SOLVATO DELLO STESSO E DARUNAVIR O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE O UN SOLVATO DELLO STESSO, IN PARTICOLARE DARUNAVIR ETANOLATO(REZOLSTA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/967, 20141121	⤷ Start Trial
European Patent Office	1689846	CR 2013 00063	Denmark	PRODUCT NAME: TRASTUZUMABEMTANSIN; REG. NO/DATE: EU/1/13/885 20131119	⤷ Start Trial
>Country	>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Description	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.